跳至主要内容
临床试验/NCT02964533
NCT02964533Unknown不适用

Thunder-Fire Moxibustion Therapy for Chronic Fatigue Syndrome on Shenque Acupoint: a Randomized Controlled Trial

Guangzhou University of Chinese Medicine1 个研究点 分布在 1 个国家目标入组 70 人开始时间: 2016年11月最近更新:
适应症

试验速览

阶段
不适用
入组人数
70
试验地点
1
主要终点
fatigue rating scale score

研究概览

简要总结

Chronic fatigue syndrome is a group of syndrome and is prevalent in adult. Thunder-fire moxibustion is a commentary therapy belonged to acupuncture therapy. To evaluate the effect and safety of thunder-fire moxibustion therapy for chronic fatigue syndrome, we apply a randomized controlled trial by recruiting chronic fatigue syndrome patient as subject, applying thunder-fire moxibustion on shenque acupoint contrasted to common moxa-stick moxibustion, taking fatigue rating scale score, the content of CD3+、CD4+、CD8+、CD4+/CD8+ as evaluation indexes. The treatment time is 20-30 minutes per session, 3-4 times a week, there are totally 15 sessions.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Outcomes Assessor)

入排标准

年龄范围
18 Years 至 65 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • 1.Clinical diagnosis of chronic fatigue syndrome, 2.Age between 18 to 65 years old. 3.Must be able to accept moxibustion treatment 4.Never receive any treatment or has suspended treatment over 2 weeks 5.Patients with good adherence, signed informed consent by themselves

排除标准

  • 1.Other primary disease caused by chronic fatigue 2.Pregnancy or breast-feeding women. 3.Merge in other serious diseases, such as severe damage in heart, liver, kidney ,lung or mental illness 4.Has took durg for insomnia treatment 5.Has received acupuncture,massage for chronic fatigue syndrome treatment 6.Suffered from infectious disease

结局指标

主要结局

fatigue rating scale score

时间窗: 5 minutes

次要结局

  • content of peripheral t-lymphocyte subsets(3 minutes)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Haili Luo

Director

Guangzhou University of Chinese Medicine

研究点 (1)

Loading locations...

相似试验